ACE2 and infection: To determine whether increasing ACE2 expression in the subcutaneous and visceral lines would also increase SARS-CoV-2 S-mediated infection, we transduced the undifferentiated subcutaneous SNPAD B and visceral VNPAD 30315 preadipocytes with a retrovirus expressing human ACE2 and selected in puromycin.